Showing results (371-380 of 514) with videos related to
Sort By:
Pageof 52
European Journal of Pharmacology|April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonistD H Albert, T J Magoc, P Tapang, et al.Pediatric Blood & Cancer|September 17, 2011
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinomaIrene Schmid, Beate Häberle, Michael H Albert, et al.Behavioural Brain Research|September 9, 2018
Nucleus incertus ablation disrupted conspecific recognition and modified immediate early gene expression patterns in 'social brain' circuits of ratsC García-Díaz, M J Sánchez-Catalán, E Castro-Salazar, et al.The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitisD H Albert, P E Malo, P Tapang, et al.International Journal of Cancer|October 16, 2019
Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohortJohannes Holzapfel, Daniela Kandels, René Schmidt, et al.Blood|September 28, 2011
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantationEva Rettinger, Andre M Willasch, Hermann Kreyenberg, et al.Journal of Medicinal Chemistry|December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailabilityPhilip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.Leukemia|October 19, 2007
Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathwayJ Zhou, M Pan, Z Xie, et al.The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2020
A Novel Complete Autosomal-Recessive STAT1 LOF Variant Causes Immunodeficiency with Hemophagocytic Lymphohistiocytosis-Like HyperinflammationDaniel F R Boehmer, Lisa M Koehler, Thomas Magg, et al.Blood|January 10, 2013
The central nervous system is a target of acute graft versus host disease in miceSteffen Hartrampf, Jarrod A Dudakov, Linda K Johnson, et al.Pageof 52